Literature DB >> 18359567

On the thermoregulatory perils of TRPV1 antagonism.

Michael J Caterina.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2008        PMID： 18359567     DOI： 10.1016/j.pain.2008.02.033

Source DB:  PubMed          Journal:  Pain        ISSN： 0304-3959            Impact factor:   6.961


× No keyword cloud information.
  4 in total

Review 1.  Transient receptor potential (TRP) channels as drug targets for diseases of the digestive system.

Authors:  Peter Holzer
Journal:  Pharmacol Ther       Date:  2011-03-21       Impact factor: 12.310

2.  [Pain measurement in animal models].

Authors:  M Busch-Dienstfertig; C Stein
Journal:  Z Rheumatol       Date:  2013-03       Impact factor: 1.372

3.  Gene therapy for pain: results of a phase I clinical trial.

Authors:  David J Fink; James Wechuck; Marina Mata; Joseph C Glorioso; James Goss; David Krisky; Darren Wolfe
Journal:  Ann Neurol       Date:  2011-07-27       Impact factor: 10.422

Review 4.  The pharmacological challenge to tame the transient receptor potential vanilloid-1 (TRPV1) nocisensor.

Authors:  P Holzer
Journal:  Br J Pharmacol       Date:  2008-09-22       Impact factor: 8.739
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.